Future Procurement Opportunity - Supply Of Lenalidomide And Pomalidomide

Pharmaceutical Management Agency New Zealand has Released a tender for Future Procurement Opportunity - Supply Of Lenalidomide And Pomalidomide in Healthcare and Medicine. The tender was released on Aug 04, 2023.

Country - New Zealand

Summary - Future Procurement Opportunity - Supply Of Lenalidomide And Pomalidomide

Deadline - login to view

MT reference number - 69839705

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

  Address - New Zealand

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 69839705

  Document Type - Tender Notices

Notice Details and Documents:

Description - Details RFx ID: 27275509 Tender Name: Future Procurement Opportunity - Supply of Lenalidomide and Pomalidomide Reference #: Open Date: Q2 2023 Indicative RFx Release Date : Q3 2023[?] Tender Type: Future Procurement Opportunity (FPO) Project Status: Initial development[?] Expected number of contracts offered: 2 Tender Coverage: Sole Agency[?] Categories: 51000000 - Drugs and Pharmaceutical Products Regions: New Zealand Required Pre-qualifications: None Contact: Pharmac Procurement Team. procurement@Pharmac.govt.nz . Overview Pharmac is planning to issue a competitive process for the supply of lenalidomide and pomalidomide. This competitive process may result in one or more of the following f

Mt Ref Id - 69839705

Deadline - Aug 22, 2024

Share

Similar Tenders :